AB0458 B Cells Depletion for the Treatment of Systemic Autoimmune Diseases

doi 10.1136/annrheumdis-2017-eular.6402
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Regulatory B Cells in Autoimmune Diseases

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2013English

The Use of Stem Cells for the Treatment of Autoimmune Diseases

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2007English

Audiovestibular Symptoms in Systemic Autoimmune Diseases

Journal of Immunology Research
MedicineAllergyImmunology
2018English

Targeting Treg Signaling for the Treatment of Autoimmune Diseases

Current Opinion in Immunology
AllergyImmunology
2015English

Inflammation and Dysmetabolism in Systemic Autoimmune Diseases

Journal of Immunology Research
MedicineAllergyImmunology
2019English

Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as a Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases

Recent Patents on Inflammation and Allergy Drug Discovery
MedicineDrug DiscoveryAllergyImmunology
2009English

Autoantibodies in Systemic Autoimmune Diseases: Specificity and Pathogenicity

Journal of Clinical Investigation
Medicine
2015English

The Clinical Significance of the Dense Fine Speckled Immunofluorescence Pattern on HEp-2 Cells for the Diagnosis of Systemic Autoimmune Diseases

Clinical and Developmental Immunology
2012English

Janus Kinases: An Ideal Target for the Treatment of Autoimmune Diseases

Journal of Investigative Dermatology Symposium Proceedings
DermatologyMedicineCell BiologyMolecular BiologyBiotechnology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy